Haemonetics Corporation

DB:HAZ Stock Report

Market Cap: €4.1b

Haemonetics Future Growth

Future criteria checks 5/6

Haemonetics is forecast to grow earnings and revenue by 24.7% and 6.2% per annum respectively. EPS is expected to grow by 25.3% per annum. Return on equity is forecast to be 25% in 3 years.

Key information

24.7%

Earnings growth rate

25.3%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate6.2%
Future return on equity25.0%
Analyst coverage

Good

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:HAZ - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20271,579267N/AN/A6
3/31/20261,456221N/AN/A10
3/31/20251,395177N/AN/A10
9/28/20241,3611243185N/A
6/29/20241,33411569135N/A
3/30/20241,309118115182N/A
12/30/20231,270127129197N/A
9/30/20231,239128199262N/A
7/1/20231,219137176250N/A
4/1/20231,169115163273N/A
12/31/20221,12996128261N/A
10/1/20221,08486116260N/A
7/2/20221,0266888216N/A
4/2/20229934376172N/A
1/1/20229532333106N/A
10/2/20219343154110N/A
7/3/2021903645295N/A
4/3/20218707972109N/A
12/26/2020884108118154N/A
9/26/2020903106120167N/A
6/27/202094696119167N/A
3/28/202098877109158N/A
12/28/20199998081132N/A
9/28/20199886851111N/A
6/29/20199774939139N/A
3/30/20199685540159N/A
12/29/20189524672196N/A
9/29/20189392182204N/A
6/30/201892223N/A205N/A
3/31/201890446N/A220N/A
12/30/2017898-17N/A197N/A
9/30/20178924N/A187N/A
7/1/20178874N/A167N/A
4/1/2017886-26N/A160N/A
12/31/201690016N/A178N/A
10/1/2016906-59N/A155N/A
7/2/2016905-66N/A143N/A
4/2/2016909-56N/A122N/A
12/26/2015893-50N/A124N/A
9/26/201589126N/A119N/A
6/27/201589920N/A123N/A
3/28/201591017N/A127N/A
12/27/201492530N/A123N/A
9/27/201493530N/A142N/A
6/28/201494339N/A140N/A
3/29/201493935N/A140N/A
12/28/201394738N/A116N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HAZ's forecast earnings growth (24.7% per year) is above the savings rate (1%).

Earnings vs Market: HAZ's earnings (24.7% per year) are forecast to grow faster than the German market (21.1% per year).

High Growth Earnings: HAZ's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HAZ's revenue (6.2% per year) is forecast to grow faster than the German market (5.7% per year).

High Growth Revenue: HAZ's revenue (6.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: HAZ's Return on Equity is forecast to be high in 3 years time (25%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y